CME Group Inc. (NASDAQ:CME – Get Free Report) announced a quarterly dividend on Thursday, August 8th, RTT News reports. Shareholders of record on Monday, September 9th will be given a dividend of 1.15 per share by the financial services provider on Wednesday, September 25th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Monday, September 9th.
CME Group has increased its dividend by an average of 9.0% annually over the last three years and has increased its dividend every year for the last 14 years. CME Group has a dividend payout ratio of 45.8% indicating that its dividend is sufficiently covered by earnings. Analysts expect CME Group to earn $9.94 per share next year, which means the company should continue to be able to cover its $4.60 annual dividend with an expected future payout ratio of 46.3%.
CME Group Stock Up 0.5 %
CME Group stock opened at $220.50 on Friday. The firm has a market cap of $79.39 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 6.51 and a beta of 0.52. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52-week low of $190.70 and a 52-week high of $223.80. The firm has a 50 day moving average price of $203.51 and a two-hundred day moving average price of $207.61.
Insider Transactions at CME Group
In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
CME has been the topic of several research reports. Barclays upped their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Keefe, Bruyette & Woods raised their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Finally, Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $212.00 to $177.00 in a research note on Tuesday. Four analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $209.73.
Get Our Latest Research Report on CME
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- How to Invest in Insurance Companies: A Guide
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
- What is Forex and How Does it Work?
- Cloud Security Stocks Face Off: Find Out Who’s Leading the Market
- Stock Splits, Do They Really Impact Investors?
- Defensive Sectors: Shielding Your Portfolio in Volatile Times
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.